|
|
Effects of Shenghua decoction combined with hemabate for threating postpartum placenta residual |
Chaoyang Hospital of Huainan, Anhui Province, 232001 |
|
|
Abstract To investigate the effect of Shenghua decoction combined with hemabate for treating women with postpartum placenta residual. Methods: 106 women with postpartum placenta residual were randomly divided into two groups (53 women in each group) according to random number table method from February 2018 to February 2019. The women in the control group were treated with hemabate and 53 women in the study group were treated with Shenghua decoction combined with hemabate, After the treatment, postpartum blood loss, uterine decline rate, serum human chorionic gonadotropin (β-hCG) level, endometrial thickness, placental residual area, excretion time of residual tissue, and adverse reactions rate of women were compared between the two groups. Results: The total effective rate of women in the study group was 90.5%, which was significant higher than that (71.7%) of women in the control group, the bleeding volume postpartum 2h or 24h of women in the study group was significant less than that of women in the control group, but the rate of uterine decline of women in the study group was significant higher than of women in the control group (all P<0.05). After treatment, β-hCG level, endometrial thickness, and placental residual area of women in both groups had decreased significantly, and those of women in the study group were significant superior to those of women in the control group (all P<0.05). The excretion time of residual tissues of women in the control group was 27.28±8.87 d, which was significant longer than that (17.63±5.19 d) of women in the study group (P<0.05), but there was no significant difference in the rate of adverse reaction (3.8% and 1.9%) of women between the two groups (P>0.05). Conclusion: Shenghua decoction combined with hemabate for threating women with postpartum placenta residual has effectiveness and safety without side effect.
|
|
|
|
|
|
|
|